AstraZeneca starts coronavirus vaccine trials in Japan

Drugmaker says it will deliver 30m doses to the country by next March

AstraZeneca has signed an agreement with the Japanese government to supply the country with 120 million doses of a COVID-19 vaccine. © Reuters

RINA MITSUTAKE, Nikkei staff writerSeptember 4, 2020 23:52 JST | Japan

TOKYO -- AstraZeneca has begun clinical trials for a coronavirus vaccine candidate in Japan, its local unit announced Friday.

Read Next